Reply to: 'A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Need a closer look!'

J Hepatol. 2024 Jun;80(6):e269-e270. doi: 10.1016/j.jhep.2024.02.005. Epub 2024 Feb 10.

Authors

Hyun Yang¹, Jeong Won Jang²

Affiliations

¹ Division of Hepatology, Department of Internal Medicine, The Catholic University of Korea, Seoul, Republic of Korea; The Catholic University Liver Research Center, Seoul, Republic of Korea.
² Division of Hepatology, Department of Internal Medicine, The Catholic University of Korea, Seoul, Republic of Korea; The Catholic University Liver Research Center, Seoul, Republic of Korea. Electronic address: garden@catholic.ac.kr.

PMID: 38346580
DOI: 10.1016/j.jhep.2024.02.005

No abstract available

Publication types

Letter

MeSH terms

Carcinoma, Hepatocellular* / etiology
Carcinoma, Hepatocellular* / virology
Hepatitis B / complications
Hepatitis B Surface Antigens* / blood
Hepatitis B Surface Antigens* / immunology
Hepatitis B, Chronic / complications
Hepatitis B, Chronic / immunology
Hepatitis B, Chronic / virology
Humans
Liver Neoplasms* / etiology
Risk Assessment / methods